Viatrexx-cellulite Breastfeeding
It is a well known fact that breastfeeding is best source of nutrition for infants. Breast milk provides minerals, vitamins and antibodies in most acceptable format when they need it. Nutrition taken by mother passes to breast-milk and same thing applies to medicines taken by mothers. Not all drugs cause problem for baby but some do. Lets analyze if Viatrexx-cellulite is safe for baby while breastfed.

What is Viatrexx-cellulite used for?

and Use Viatrexx-Cellulite a sterile, injectable, biodegradable, clear isotonic liquid that is injected into the various layers of the skin, adipose, cellulite, other body tissues or added to an IV, either as a push or into the bag.

Is Viatrexx-cellulite usage safe while breastfeeding? If a lactating mother is using it can there be any effect on growth or development of infant?

Viatrexx-cellulite Contains 31 active ingredients that are Androsterone, Artichoke, Adenosine triphosphate, Basic fibroblast growth factor (human), Ersofermin, Adenosine cyclic phosphate, Levocarnitine, Centella asiatica, Anhydrous citric acid, Cobalt, Estrogens, esterified, Ferrous cation, Fumaric acid, Heptaminol, Hamamelis virginiana bark, Hyaluronidase, Interleukin-3, Potassium aspartate, Lactic acid, Bos taurus lymph vessel, Sus scrofa lymph vessel, Melilotus officinalis whole, Manganese, Sodium diethyl oxalacetate, Sodium pyruvate, Quinhydrone, Succinic acid, Bos taurus vein, Sus scrofa vein, Vitamin a, Zinc. We do have breastfeeding analysis and safety rating of some of the active ingredients but unfortunately we do not have any information of some of active ingredients used. Below we have provided whatever information we do have. But please do not take any decision based on below provided information and contact your health care provider as this information is incomplete.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers It is not known whether the benzyl alcohol or any of the ingredients is excreted in human milk. Caution should be exercised when products with benzyl alcohol are administered to nursing woman.

Viatrexx-cellulite Breastfeeding Analsys

Artichoke while Breastfeeding


At latest update, relevant information on excretion into breast milk was not found. Plant largely used as food, infusion (tea) and extract. Because of a lack of toxicity, a moderate use as Phytotherapy during breastfeeding, is thought to be of low or nil risk. Herbal leaves are used. Constituents are: Lactones, phenol acids, flavonoids, steroids. Not proven effects: cholagogue, liver protector, hypocholesterolemic effect.

Levocarnitine while Breastfeeding


CAS Number: 406-76-8

Amino acid that is present in many foods, among them the milk. Indication is the treatment of Primary Deficiency of Carnitine, or, Secondary Deficiency due to Hemolysis, Myocardiopathy and other diseases. Only Levocarnitine is effective as a supplement, with the consumption of D-carnitine regarded as a risk for deficiency. Normal levels in the milk are not modified by the consumption of supplements of Carnitine. Mean concentration level within the first month is about 10 to 12 mg/L, with lower levels in the next following months. The supplementation with Carnitine of the milk for premature infants does not improve their weight increment, with no proof of a beneficial effect.

Centella asiatica while Breastfeeding


Is Viatrexx-cellulite safe while breastfeeding

At latest update, relevant published data on excretion into breast milk were not found. It contains triterpenic saponins (asiaticoside and madecassoside), tannins, phytosterols and essential oil. Frequent and exaggerated use of triterpenes may cause liver damage. Properties that are attributed for topical use (some clinically tested) like are healing of wound and venous tonic. There is no proof on effectiveness when used by mouth. Because of a low or nil systemic absorption through skin or vaginal mucosa, the topical use is believed be compatible with breastfeeding. Do not use it on the breast or clean it thoroughly to avoid ingestion by the infant. Avoid oral administration.

Anhydrous citric acid while Breastfeeding


CAS Number: 77-92-9

Product that is naturally found in most fruits, especially citrus ones, and which is industrially produced through fermentation of sugar by the fungus Aspergillus niger. It is used in medical compounds as effervescent, to treat intestinal affections, as antioxidant, as an agent for alkalizing urine and dissolution of urinary tract stones. In the food industry it is used as additive (E 330) due to its antioxidant, preservative and flavoring properties. Devoid of toxicity when used at appropriate doses.

Cobalt while Breastfeeding


CAS Number: 7440-48-4

Gray powder or metal, odorless. There is a risk of asthma crisis if cobalt powder is inhaled. It can be a cause of skin, ocular and respiratory tract irritation. Acetate, sulfate, trioxide and nitrate cobalt salts are potentially carcinogenic. Mandatory measures to prevent inhalation (room air extraction and respiratory protection) and ingestion (avoid eating, drinking or smoking in the work place). The industry must ensure a Threshold Limit Value (TLV) (TWA as well) less than 0.05 mg/m3 (cobalt salts less than 0.002 mg/m3). Biological Exposition Index (BEI) on the last labor week day: 15 micrograms/L in the urine, 1 microgram/L in the blood. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other foods. (Codex alimentarius FAO-WHO).

Estrogens, esterified while Breastfeeding

Low Risk

CAS Number: 50-28-2

Viatrexx-cellulite safe for breastfeeding

A natural Estrogen that is marketed for oral, injection and topical administration (skin and vaginal).On the chemical form of valerate, it is used in association with a progestin as a combined birth-control compound (e.g. Estradiol + Dienogest) Estradiol is excreted into breast milk in clinically non-significant amount (Nilson 1978) and no problems have been observed in infants whose mothers were treated (Pinheiro 2016). Plasma levels of these infants were undetectable or very low (Pinheiro 2016). After administration in the form of transdermal patches milk levels have been undetectable (Pinheiro 2016, Perheentupa 2004). Despite these data, an older publication associated the use of transdermal estradiol with a case of jaundice and poor weight gain (Ball 1999).There is greater passage to milk when the administration is vaginal. There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartumThey may reduce the protein content of the milk. No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. Estrogen exposure in childhood or adolescence, does not influence the subsequent production of milk. The American Academy of Pediatrics states that this medication is usually compatible with breastfeeding.

Ferrous cation while Breastfeeding


CAS Number: 141-01-5

Several ferrous salts of iron (ascorbate, aspartate, citrate, chloride, fumarate, gluconate, lactate, oxalate, succinate, sulfate, glycine sulfate, etc.) are used in oral administration for treating or preventing iron deficiency anemia.Its molecular weight varies from 170 for the fumarate and succinate, and from 280 for lactate and sulfate to 400 for aspartate and ascorbate. Characteristics of iron metabolism in the body make unlikely that it would be excreted in a significant amount into breast milk.It is a medication used for treatment of Neonatal Anemia in premature babies. Iron is excreted in small amounts in human milk, usually being enough for covering the daily needs of infants due to its high bioavailability. There is no correlation between mother's daily intake of iron and its concentration in breast milk.Iron supplementation to the mother does not increase levels of iron in breast milk or infant plasma significantly. Excessive supplementation can reduce the zinc concentration in milk. WHO List of Essential Medicines 2002: compatible with breastfeeding.

Fumaric acid while Breastfeeding

Low Risk

CAS Number: 110-17-8

Anti-inflammatory and immunomodulator used in the treatment of psoriasis and in relapsing forms of multiple sclerosis. Since the last update we have not found published data on its excretion in breast milk. Its pharmacokinetic data (large volume of distribution and short half-life) make it unlikely that milk would pass through in significant quantities (Almas 2016).Possible side effects are rare and generally not serious, with no immunosuppressive effects or higher frequency of infections (EMA 2017, AEMPS 2015). Until there is more published data on this drug in relation to breastfeeding, known safer alternatives may be preferable, especially during the neonatal period and in case of prematurity (Brown 2017, Yiu 2015, Bove 2014, Cree 2013).

Heptaminol while Breastfeeding


Systemic vasodilator, which is marketed in association with other substances to improve brain function, and, as treatment of dizziness and mental disorders. It has not been shown any benefit. Overall, associations of multiple drugs are not recommended.

Hamamelis virginiana bark while Breastfeeding


Leaves of the plant and sometimes bark also are used. It contains tannins, pro anthocyanidins and flavonic heterosides (quercitrin, isoquercitrin). Venous-tonic and anti-inflammatory properties have not been well established. The Commission E of the German Ministry of Health authorizes its use locally and by suppositories.

Hyaluronidase while Breastfeeding


CAS Number: 9001-54-1

Enzyme obtained from testes of mammals that acts by depolymerization of mucopolysaccharides like hyaluronic acid. It is used to facilitate the diffusion of local anesthetics.

Potassium aspartate while Breastfeeding


CAS Number: 7447-40-7

Human milk has a potassium concentration of 13 meq/L, almost a half of rehydration solution content and a quarter of maximal IV recommended dose. Potassium supplementation does not alter milk concentration without increasing mother’s serum concentration, which is strictly limited from 3,5 to 5,5 meq/L.

Lactic acid while Breastfeeding


CAS Number: 50-21-5

A natural product found in milk that may increase their concentration after exercise which is not harmful to the infant. At latest update published were not found data on excretion in breast milk.Because the small dose used and poor absorption to the plasma of most topical dermatological or vaginal preparations, make it unlikely the pass of a significant amount into breast milk. Do not apply on the nipple or areola.

Quinhydrone while Breastfeeding

Low Risk

CAS Number: 123-31-9

Benzene derivative which is topically used with creams and solutions (2-4%) as a bleaching agent for several skin disorders associated to hyper-pigmentation. In industry it is used as photographic developer. TLV or threshold limit value which means maximum exposure limit for workers is 2 mg / m3 (Flickinger 1976). At latest update relevant published data were not found on excretion into breast milk. It is well absorbed through the skin, both when used as a therapeutic agent (Bucks 1998, Wester 1998, Westerhof 2005, Andersen 2010, Bozzo 2011) or industrial use (Barber 1995, McGregor 2007), however, a significant excretion into breastmilk is not likely for their lack of fat solubility. There is controversy and doubt about a possible mutagenic and carcinogenic effect (Kooyers 2004, FDA 2006, Levitt 2007, Andersen 2010), so it does not seem wise a chronic or continued use while breastfeeding. Do not apply it on the breast to prevent ingestion by the infant; otherwise, do it just after a meal and clean the nipple thoroughly with water before the next feed.Do not apply it over large areas or on long-term treatments to avoid an excessive systemic absorption.

Vitamin a while Breastfeeding


CAS Number: 68-26-8

Retinol is also a name for vitamin A which is a natural component of human milk. Content in the human milk is about 2,800 IU/L (750 μ/L). Infant's recommended dietary daily allowance is 2,000 IU (600 μ/L). Mother's recommended daily allowance is 3,200 IU (950 μ/L). There is a risk for severe intoxication after an isolated dose of 25,000 IU or long-standing daily consumption of 5,000 IU. After a megadose administration of vitamin A increases concentration to a double in the colostrum. Supplementation with vitamin A to breastfeeding mothers or infants does not reduce mortality or morbidity among HIV affected offsprings, instead it increases the likelihood of transmission of HIV or subclinical mastitis in those mothers infected with HIV. Vitamin A is widely distributed in the food of animal or vegetable origin. Except for populations affected with food shortage or nutritionally deficient, those women on a complete and varied diet do not need the intake of vitamin A supplementation The List of Essential Medicines of WHO-2002 classifies it as compatible with breastfeeding.

Zinc while Breastfeeding


Zinc (Zn) is an essential element for nutrition. It is present in many foods.Recommended daily allowance of Zn is 8 to 15 mg. (Moran Hall 2010). Millions of people worldwide are Zn-deficient.It is used as a treatment for Wilson's disease and Acrodermatitis Enteropathica. Zn is involved in the regulation process of lactation (Lee 2016).Pasteurization of the milk does not affect the concentration of Zn and other trace elements (Mohd Taufek-2016). The average concentration of Zn in breastmilk is 4 to 16 mg / L (Picciano 1976, Hannan 2005, Dórea 2012) which is independent of plasma levels and maternal daily intake (Krebs 1995, Chierici 1999, Hannan 2009).Intestinal absorption of zinc is almost doubled during pregnancy and lactation (Fung 1997).Zinc levels in the infant are dependent on Zinc levels in the breast milk (Dumrongwongsiri 2015)With a varied and balanced diet, an extra intake of minerals is not needed. Excessive intake of Zinc may cause gastrointestinal problems and Pancytopenia (Irving 2003).

Viatrexx-cellulite Breastfeeding Analsys - 2

Levocarnitine while Breastfeeding

CAS Number: 541-15-1; 3040-38-8;

Levocarnitine and acetyl-l-carnitine (acetlycarnitine) are normal components of human milk that are required for fat metabolism. The body can use only levocarnitine, and dextrocarnitine can be an antagonist of levocarnitine. Acetyl-l-carnitine, and propionyl-l-carnitine can be converted to levocarnitine by the body. The bioavailability of levocarnitine is less than 20%, but acetylcarnitine and propionlycarnitine may be higher. These substances have no specific lactation-related uses. Within the normal range of dietary intake, excretion of levocarnitine into breastmilk is relatively constant. Women with carnitine deficiency appear to secrete insufficient amounts of carnitine into their breastmilk for their breastfed infants, who may require levocarnitine supplementation.[1] Preterm infants are often deficient in levocarnitine and require supplementation.[2] No data exist on the safety and efficacy levocarnitine supplementation in nursing mothers or infants without carnitine deficiency. Levocarnitine and its derivatives are generally well tolerated in adults with occasional gastrointestinal upset and restlessness. A fishy odor to the breath, sweat and urine has been reported. Although data are very limited, poor bioavailability might limit absorption by the breastfed infant. It appears unlikely that maternal levocarnitine supplements during nursing would be harmful to the infant, but until more data are available, it is probably best to avoid levocarnitine supplementation unless it is prescribed by a healthcare professional. Pasteurization (method not stated) had little effect on the concentration of endogenous carnitine in one study. Pasteurization followed by refrigeration at 5 degrees C for 48 hours reduced the carnitine concentration by about 13%.[3]

Estrogens, esterified while Breastfeeding

CAS Number: 50-28-2

Limited information on the use of estradiol during breastfeeding indicates that the route of administration and dosage form have influences on the amount transferred into breastmilk. Vaginal administration results in measurable amounts in milk, but transdermal patches do not. Maternal doses of up to 200 mcg daily transdermally do not increase estradiol or estriol in breastfed infants or cause any adverse effects in breastfed infants. Vaginal administration results in unpredictable peak times for estradiol in breastmilk, so timing of the dose with respect to breastfeeding is probably not useful. A case report of inadequate milk production and inadequate infant weight gain was possibly caused by transdermal estradiol initiated on the first day postpartum, but 2 small studies found no such effect when the drug was initiated after lactation was well established.

Quinhydrone while Breastfeeding

CAS Number: 123-31-9

Topical hydroquinone has not been studied during breastfeeding. Hydroquinone is not contraindicated during breastfeeding and if hydroquinone is required by the mother, it is not a reason to discontinue breastfeeding. However, some experts feel that long-term use of hydroquinone is difficult to justify in a nursing mother.[1] If hydroquinone is used, ensure that the infant's skin does not come into direct contact with the areas of maternal skin that have been treated and the infant does not ingest the product from the mother's skin.

Vitamin a while Breastfeeding

CAS Number: 68-26-8 79-81-2

Routine, modest daily supplemental vitamin A results in modest increases in milk vitamin A content and appears to be safe for the infant. Vitamin A (retinol) and provitamin A carotenoids are normal components of human milk.[1] The recommend dietary intake in lactating women is 1300 mcg retinol per day, compared to 770 mcg per day during pregnancy. The recommended daily intake for infants aged 6 months or less is 400 mcg. .[2] Lactating mothers may need to supplement their diet to achieve the recommended daily vitamin A intake. Maternal vitamin A supplementation during pregnancy and lactation has not been shown to reduce mortality or the risk of anemia in breastfed infants living in developing regions, but there may be undiscovered benefits related to improved antioxidant capacity and immune function.[3][4][5] Maternal single doses up to 120,000 mcg or daily doses up to 1500 mcg are not expected to harm the breastfed infant. Daily doses above 3,000 mcg should be avoided in the mother. [2] Vitamin A in milk has antioxidant properties.[6] Holder pasteurization (62.5 degrees C for 30 minutes) does not reduce milk antioxidant capacity.[7]

What should I do if already breastfed my kid after using Viatrexx-cellulite?

Not much study has been done on safety of Viatrexx-cellulite in breastfeeding and its ingredients. Even we do not have complete information about usage of Viatrexx-cellulite in breastfeeding so at this point a trained medical professional could be your best bet. If you observe anything abnormal with your baby please contact 911.

I am nursing mother and my doctor has suggested me to use Viatrexx-cellulite, is it safe?

If your doctor considers Viatrexx-cellulite safe enough to prescribe for you that means its benefits should outweigh its known risks for you.

If I am using Viatrexx-cellulite, will my baby need extra monitoring?

We are not Sure, Please check with your healthcare provider or doctor.

Who can I talk to if I have questions about usage of Viatrexx-cellulite in breastfeeding?

National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week